Literature DB >> 15568210

Semi-parametric modelling for costs of health care technologies.

C Conigliani1, A Tancredi.   

Abstract

Cost data that arise in the evaluation of health care technologies usually exhibit highly skew, heavy-tailed and, possibly, multi-modal distributions. Distribution-free methods for analysing these data, such as the bootstrap, or those based on the asymptotic normality of sample means, may often lead to inefficient or misleading inferences. On the other hand, parametric models that fit the data (or a transformation of the data) equally well can produce very different answers. We consider a Bayesian approach, and model cost data with a distribution composed of a piecewise constant density up to an unknown endpoint, and a generalized Pareto distribution for the remaining tail. 2005 John Wiley & Sons, Ltd.

Mesh:

Substances:

Year:  2005        PMID: 15568210     DOI: 10.1002/sim.2012

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  3 in total

1.  Costing and cost analysis in randomized controlled trials: caveat emptor.

Authors:  Daniel Polsky; Henry Glick
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

Review 2.  Review of statistical methods for analysing healthcare resources and costs.

Authors:  Borislava Mihaylova; Andrew Briggs; Anthony O'Hagan; Simon G Thompson
Journal:  Health Econ       Date:  2010-08-27       Impact factor: 3.046

3.  Confounding and missing data in cost-effectiveness analysis: comparing different methods.

Authors:  Tommi Härkänen; Timo Maljanen; Olavi Lindfors; Esa Virtala; Paul Knekt
Journal:  Health Econ Rev       Date:  2013-03-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.